Maury Raycroft

Q: What is Maury Raycroft's success rate?

Maury Raycroft currently has a success rate of 84.84002891591766.

Q: What is the average return of Maury Raycroft's calls?

Their stock ratings have generated an average return of 48.120841828266364.

Jefferies | Healthcare

Maury Raycroft is an analyst from Jefferies specializing in the Healthcare sector. Ranked #456 out of 4771 analysts, they have issued 16 stock ratings with a success rate of 84.84% and an average return of 48.12%.

With 16 ratings to date, Maury Raycroft is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 84.84% and an average return of 48.12%, highlighting promising potential as their track record develops further.

#456

Out of 4771

Total Ratings

+84.84%

Success Rate

+48.12%

Average Return

Recent Ratings Analysis

ANL

Buy

Sep 10, 2026

Target

$31.00

Current

$15.09

Performance

0.00%

Maury Raycroft rated ANL as Buy on Sep 10, 2026, setting a price target of 31. Shares have remained stable near 15.09, leaving the 31 target still in play.

RARE

Buy

Sep 03, 2026

Target

$77.00

Current

$14.40

Performance

-3.03%

On Sep 03, 2026, RARE was given a Buy rating by Maury Raycroft, with a target price of 77. The stock traded sideways with a -3.03% move, keeping the bullish thesis unresolved.

COAG

Buy

Jul 13, 2026

Target

$47.00

Current

$39.88

Performance

0.94%

COAG received a Buy rating from Maury Raycroft on Jul 13, 2026, aiming for 47. Price action was muted, as shares hovered around 39.88 despite the bullish outlook.

TNGX

Buy

Jun 26, 2026

Target

$60.00

Current

$23.37

Performance

-25.74%

On Jun 26, 2026, Maury Raycroft published a Buy outlook on TNGX, with a target of 60. Market action contradicted the Buy thesis, as shares slipped to 23.37.

CRBP

Buy

May 13, 2026

Target

$33.00

Current

$8.24

Performance

-32.18%

Maury Raycroft on May 13, 2026 assigned CRBP a Buy rating, with a price target of 33. The call has struggled to gain traction, with shares losing 32.18%.

TYRA

Buy

Feb 03, 2026

Target

$43.00

Current

$23.54

Performance

-24.65%

On Feb 03, 2026, Maury Raycroft reaffirmed TYRA with a Buy rating, targeting 43. Shares slid 24.65% despite the recommendation, highlighting downside risks.

DNTH

Buy

Feb 02, 2026

Target

$81.00

Current

$103.28

Performance

94.21%

DNTH was rated Buy by Maury Raycroft on Feb 02, 2026, with a price objective of 81. A bullish response from the market helped close the gap of -22.28 to the target.

MREO

Hold

Dec 30, 2025

Target

$7.00

Current

$0.24

Performance

-33.98%

On Dec 30, 2025, Maury Raycroft initiated coverage on MREO with a Hold rating and target of 7. The rating matched the stock’s inability to hold above 0.2446.

CELC

Buy

Dec 02, 2025

Target

$134.00

Current

$85.49

Performance

-12.32%

Maury Raycroft issued a Buy recommendation for CELC on Dec 02, 2025, price target set at 134. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

AUPH

Buy

Nov 07, 2025

Target

$21.00

Current

$16.11

Performance

10.27%

On Nov 07, 2025, AUPH was evaluated by Maury Raycroft, who gave a Buy rating and target of 21. This case illustrates how a timely bullish rating can translate into tangible gains of 10.27%.

OPK

Hold

Oct 31, 2025

Target

$1.60

Current

$1.49

Performance

9.56%

Maury Raycroft rated OPK as Hold on Oct 31, 2025, setting a price target of 1.6. Despite the Hold call, shares climbed 9.56% to 1.49, revealing unexpected momentum.

ALNY

Buy

Oct 30, 2025

Target

$549.00

Current

$247.51

Performance

-44.94%

On Oct 30, 2025, ALNY was given a Buy rating by Maury Raycroft, with a target price of 549. Despite the Buy call, shares fell from 247.51 to 247.51, challenging the optimistic stance.

KZR

Hold

Oct 17, 2025

Target

$7.00

Current

$7.29

Performance

14.62%

KZR received a Hold rating from Maury Raycroft on Oct 17, 2025, aiming for 7. Investors saw gains of 14.62% that the cautious stance didn’t fully capture.

KOD

Buy

Sep 22, 2025

Target

$15.00

Current

$32.87

Performance

118.99%

On Sep 22, 2025, Maury Raycroft published a Buy outlook on KOD, with a target of 15. Shares gained 118.99%, underscoring the accuracy of the bullish outlook toward 15.

CRDF

Hold

Jun 24, 2025

Target

$3.50

Current

$1.21

Performance

-62.19%

Maury Raycroft on Jun 24, 2025 assigned CRDF a Hold rating, with a price target of 3.5. The call successfully avoided chasing as shares lost 62.19%.

CMRX

Hold

Mar 05, 2025

Target

$8.50

Current

$8.54

Performance

0.95%

On Mar 05, 2025, Maury Raycroft reaffirmed CMRX with a Hold rating, targeting 8.5. The neutral call matched muted market action of 0.95%.

CMPX

Buy

Feb 10, 2025

Target

$8.00

Current

$2.05

Performance

-47.44%

CMPX was rated Buy by Maury Raycroft on Feb 10, 2025, with a price objective of 8. This case shows how bullish projections can fail, with the stock now below 2.05.

SGMO

Buy

Dec 31, 2024

Target

$3.00

Current

$0.07

Performance

-92.75%

On Dec 31, 2024, Maury Raycroft initiated coverage on SGMO with a Buy rating and target of 3. The Buy call has yet to be validated as shares remain 2.93 away from the target.

ERAS

Buy

Nov 18, 2024

Target

$6.00

Current

$16.03

Performance

487.18%

Maury Raycroft issued a Buy recommendation for ERAS on Nov 18, 2024, price target set at 6. Investors following the Buy call captured upside momentum, with shares now at 16.03.

CALT

Hold

May 28, 2024

Target

$39.00

Current

$40.00

Performance

5.40%

On May 28, 2024, CALT was evaluated by Maury Raycroft, who gave a Hold rating and target of 39. Investors who stayed in despite the Hold saw upside of 5.40%.

PRME

Buy

May 07, 2024

Target

$15.00

Current

$3.35

Performance

-39.86%

Maury Raycroft rated PRME as Buy on May 07, 2024, setting a price target of 15. The stock has underperformed, dropping 39.86% despite the bullish target of 15.

Frequency Asked Questions

Who is Maury Raycroft?

Maury Raycroft is an analyst from Jefferies specializing in the Healthcare sector.

What is Maury Raycroft's success rate?

Maury Raycroft currently has a success rate of +84.84%.

How many ratings has Maury Raycroft issued?

Maury Raycroft has issued 16 stock ratings so far.

What is the average return of Maury Raycroft's calls?

Their stock ratings have generated an average return of +48.12%.

What is Maury Raycroft's ranking?

Maury Raycroft is ranked #456 out of 4771 analysts.

What types of ratings does Maury Raycroft give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Maury Raycroft?

You can follow Maury Raycroft by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Maury Raycroft?

Their latest rating was a Buy on ANL issued on 2026-09-10.